Johnson & Johnson
Media
Johnson & Johnson Acquires Intra-Cellular Therapies for $14.6 Billion, Expanding Mental Health Portfolio
In a significant move that reshapes the landscape of mental health therapeutics, Johnson & Johnson (NYSE: JNJ) announced today its acquisition of Intra-Cellular...
Business
J&J and Kenvue Ordered to Pay $45M in Talcum Lawsuit
An Illinois court has ordered pharmaceutical giant Johnson & Johnson and Kenvue to pay $45 million to a family. They alleged that the...
CFO Network
Joe Wolk: CFO at Heart of Johnson & Johnson’s Transformation
Joe Wolk, Chief Financial Officer of Johnson & Johnson, embodies the company’s evolution. With the recent separation of its consumer health business into...
